These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 15626892

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Response to infliximab is related to disease duration in paediatric Crohn's disease.
    Lionetti P, Bronzini F, Salvestrini C, Bascietto C, Canani RB, Dé Angelis GL, Guariso G, Martelossi S, Papadatou B, Barabino A.
    Aliment Pharmacol Ther; 2003 Aug 15; 18(4):425-31. PubMed ID: 12940928
    [Abstract] [Full Text] [Related]

  • 4. Use of infliximab in pediatric patients with inflammatory bowel disease.
    Serrano MS, Schmidt-Sommerfeld E, Kilbaugh TJ, Brown RF, Udall JN, Mannick EE.
    Ann Pharmacother; 2001 Aug 15; 35(7-8):823-8. PubMed ID: 11485127
    [Abstract] [Full Text] [Related]

  • 5. Use of infliximab in the treatment of Crohn's disease in children and adolescents.
    Hyams JS, Markowitz J, Wyllie R.
    J Pediatr; 2000 Aug 15; 137(2):192-6. PubMed ID: 10931411
    [Abstract] [Full Text] [Related]

  • 6. Prolonged duration of response to infliximab in early but not late pediatric Crohn's disease.
    Kugathasan S, Werlin SL, Martinez A, Rivera MT, Heikenen JB, Binion DG.
    Am J Gastroenterol; 2000 Nov 15; 95(11):3189-94. PubMed ID: 11095340
    [Abstract] [Full Text] [Related]

  • 7. Infliximab in clinical routine: experience with Crohn's disease and biomarkers of inflammation over 5 years.
    Lönnkvist MH, Befrits R, Lundberg JO, Lundahl J, Fagerberg UL, Hjortswang H, van Hage M, Hellström PM.
    Eur J Gastroenterol Hepatol; 2009 Oct 15; 21(10):1168-76. PubMed ID: 19757522
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of repeated infliximab infusions for Crohn's disease: 1-year clinical experience.
    Cohen RD.
    Inflamm Bowel Dis; 2001 May 15; 7 Suppl 1():S17-22. PubMed ID: 11380038
    [Abstract] [Full Text] [Related]

  • 9. Combining infliximab with methotrexate for the induction and maintenance of remission in refractory Crohn's disease: a controlled pilot study.
    Schröder O, Blumenstein I, Stein J.
    Eur J Gastroenterol Hepatol; 2006 Jan 15; 18(1):11-6. PubMed ID: 16357613
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Use of infliximab in the treatment of Crohn's disease in children and adolescents.
    Hyams JS.
    J Pediatr Gastroenterol Nutr; 2001 Sep 15; 33 Suppl 1():S36-9. PubMed ID: 11685974
    [No Abstract] [Full Text] [Related]

  • 14. Infliximab improves inflammation and anthropometric measures in pediatric Crohn's disease.
    Sinitsky DM, Lemberg DA, Leach ST, Bohane TD, Jackson R, Day AS.
    J Gastroenterol Hepatol; 2010 Apr 15; 25(4):810-6. PubMed ID: 20492339
    [Abstract] [Full Text] [Related]

  • 15. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
    Magro F, Portela F.
    BioDrugs; 2010 Dec 14; 24 Suppl 1():3-14. PubMed ID: 21175228
    [Abstract] [Full Text] [Related]

  • 16. The impact of infliximab induction therapy on mucosal healing and clinical remission in Polish pediatric patients with moderate-to-severe Crohn's disease.
    Kierkus J, Dadalski M, Szymanska E, Oracz G, Wegner A, Gorczewska M, Szymanska S, Woynarowski M, Ryzko J.
    Eur J Gastroenterol Hepatol; 2012 May 14; 24(5):495-500. PubMed ID: 22387887
    [Abstract] [Full Text] [Related]

  • 17. Biosimilar infliximab (CT-P13) in the treatment of inflammatory bowel disease: A Norwegian observational study.
    Jahnsen J, Detlie TE, Vatn S, Ricanek P.
    Expert Rev Gastroenterol Hepatol; 2015 May 14; 9 Suppl 1():45-52. PubMed ID: 26395534
    [Abstract] [Full Text] [Related]

  • 18. [Indications and results of infliximab in Crohn's disease].
    Karoui S, Boubaker J, Filali A.
    Tunis Med; 2004 Dec 14; 82(12):1057-63. PubMed ID: 15822505
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.